Gyrus Capital is an investment firm specializing in healthcare and sustainability sectors, targeting long-term growth by supporting businesses that address societal and environmental needs. Based in Geneva, Switzerland, the company focuses on transformational investments in small to medium-sized enterprises, leveraging sector expertise to drive change and value creation.
- Pharmaceuticals
- Specialty Pharmaceuticals
- Central Nervous System (Cns) Drugs
- Chronic Disease Medicines
- Acute Care Medicines
- Niche Medicines
Leadership
| Name | Title | ||
|---|---|---|---|
| Robert Watson | Partner |
in/robert-watson-583994
|
|
| Partner |
|
|
|
| Partner |
|
|
|
| Partner |
|
|
|
| Partner |
|
|
|
| Partner |
|
|
|
| Partner |
|
|
|
| Principal |
|
|
|
| Principal |
|
|
Recent Transactions involving Gyrus Capital
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Gyrus Capital investment into Neo Medical |
Neo Medical |
Gyrus Capital |
Medical Technology | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →